Skip to main content

Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time.

Pidcoke HF, McFaul SJ, Ramasubramanian AK, Parida BK, Mora AG, Fedyk CG, Valdez-Delgado KK, Montgomery RK, Reddoch KM, Rodriguez AC, Aden JK, Jones JA, Bryant RS, Scherer MR, Reddy HL, Goodrich RP, Cap AP

Publication: Transfusion (2013) • Vol 53 Suppl 1 • Page 137S-149SPMID: 23301966View on PubMed

Purpose

The purpose of this paper was to determine the effects of storage temperature and pathogen reduction technology (PRT) treatment on markers of blood quality.

Conclusion

During storage, lactate, prothrombin time (PT), activated partial thromboplastin time (aPTT), and hemolysis increased, and granulocyte counts, platelet (plt) counts, glucose, pH, factor V, factor VIII, protein C, antithrombin III, glycoprotein Ib alpha (GPIb) expressing plt population, and agonist-stimulated and unstimulated plt aggregation decreased, while thromboelastography (TEG) parameters and fibrinolysis were significantly altered. The changes in lactate, glucose, granulocyte counts, PT, pH, TEG parameters, fibrinolysis, protein C, factor VIII, antithrombin III, GPIb expressing plt population, and agonist-stimulated and unstimulated plt aggregation were larger in specimens stored at room temperature compared to those that were refrigerated. The storage induced changes in glucose, fibrinolysis, and, in some cases, agonist stimulated platelet aggregation, were significantly attenuated by PRT treatment, but the changes in granulocyte count, PT, aPTT, factor V, factor VIII and some TEG parameters were larger in PRT-treated specimens than untreated specimens. Hematocrit (Hct), hemoglobin (Hb), D-dimer, red blood cell (RBC) counts, fibrinogen, von Willebrand factor, most microparticle (MP) subpopulations and soluble CD40 ligand were not significantly affected by storage duration or temperature.

Studies (3)

Purpose

The purpose of this study was to determine the effects of storage duration and temperature and PRT-treatment on markers of blood quality. Blood was collected in citrate-phosphate-dextrose (CPD), and half of the specimens were PRT treated in illumination bags by addition of riboflavin and exposure to ultraviolet (UV) light. Specimens were then transferred to storage bags, kept in metal lined storage containers at each temperature, and sampled aseptically.

Summary of Findings

Lactate increased and glucose and pH decreased with storage, and changes were larger at 22 degrees C compared to at 4 degrees C (p<0.0001, p<0.0001, and p<0.001, respectively). Only the changes in glucose were significantly attenuated by PRT treatment (p<0.008). Hemolysis was unaffected by refrigerated storage but increased during storage at room temperature, especially at day 7 (p=0.014) and beyond. Plt counts decreased with storage at 4 degrees C and PRT treatment. Granulocytes decreased with storage, particularly at room temperature, or with PRT treatment. Clinically irrelevant but statistically significant decreases in white blood cell (WBC) counts were observed during storage, especially in PRT treated specimens. Hct, Hb, RBC counts, D-dimer and soluble CD40 ligand were not significantly affected by storage. PT and aPTT increased with storage duration, but the increase in PT was attenuated by refrigeration, and PT and aPTT were higher in PRT treated specimens than untreated specimens. Agonist stimulated plt aggregation decreased with storage (p<0.001), but the decrease was attenuated by refrigeration. PRT treatment attenuated the storage induced decreases in collagen, thrombin receptor-activating peptide-6, and low ristocetin (RL)-stimulated aggregation compared with untreated specimens (p=0.033) but did not affect adenosine diphosphate (ADP), arachidonic acid agonist (ASPI), and high ristocetin-stimulated aggregation. TEG clotting time (R), clot formation (K), maximum amplitude (MA), clot strength, and total thrombin generation (TTG) were affected by storage at room temperature but remained relatively stable during storage at 4 degrees C. Changes in TEG R, K, alpha angle, and MA during storage were greater in PRT treated specimens then untreated specimens. Fibrinolysis was affected by storage at room temperature, but changes were attenuated by refrigeration (p=0.012) or PRT-treatment (p<0.001).
  • Biospecimens

    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Normal
  • Platforms

    Cell count/volumeHematology/ auto analyzer
    Cell count/volumeFlow cytometry
    MorphologyHematology/ auto analyzer
    ProteinHematology/ auto analyzer
    ProteinELISA
    GlycoproteinHematology/ auto analyzer
    PeptideHematology/ auto analyzer
    CarbohydrateClinical chemistry/auto analyzer
    Small moleculeClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen Aliquots and ComponentsBlood processing method
    PRT treated
    Untreated
    StorageStorage conditions
    PRT-treated
    Untreated
    StorageStorage duration
    0 days
    1 day
    14 days
    2 days
    21 days
    3 days
    4 days
    5 days
    6 days
    7 days
    StorageStorage temperature
    22 degrees C
    4 degrees C
    Hematology/ auto analyzer SpecificReaction solution
    ADP
    Arachidonic acid
    Collagen
    High ristocetin
    Low ristocetin
    TRAP-6